The 29th Annual Meeting of Japan Society of Gene and Cell Therapy

Presentation information

Oral Session

[O13] Oral Session 13"Cancer 2"

Wed. Sep 13, 2023 1:35 PM - 2:55 PM Room 3 (1008, 10F, OICC)

Chairs:Hiroshi Tazawa(Center for Innovative Clinical Medicine, Okayama University Hospital),Tomoyuki Nishikawa()

[O13-3] SALL4 promoter-controlled oncolytic adenovirus inhibits rhabdoid tumors growth in vitro and in vivo

Hideki Yoshida1, Satoru Oya1, Mitsuru Miyachi1, Shigeki Yagyu1, Yoshiki Katsumi1, Ken Kikuchi1, Kunihiko Tsuchiya1, Eiichi Konishi2, Masato Yamamoto3, Tomoko Iehara1 (1.Department of Pediatrics, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan, 2.Department of Surgical Pathology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan, 3.Division of Basic and Translational Research, Department of Surgery, University of Minnesota, MN, USA)

Abstract password authentication.
The password was sent to all registrants in email.

Password